Dysregulation of the hippo pathway signaling in aging and cancer

Publication date: Available online 22 March 2019Source: Pharmacological ResearchAuthor(s): Yiu To Yeung, Angelica Guerrero-Castilla, Mercedes Cano, Mario F. Muñoz, Antonio Ayala, Sandro ArgüellesAbstractHuman beings are facing emerging degenerative and cancer diseases, in large part, as a consequence of increased life expectancy. In the near future, researchers will have to put even more effort into fighting these new challenges, one of which will be prevention of cancer while continuing to improve the aging process through this increased life expectancy. In the last few decades, relevance of the Hippo pathway on cancer has become an important study since it is a major regulator of organ size control and proliferation. However, its deregulation can induce tumors throughout the body by regulating cell proliferation, disrupting cell polarity, releasing YAP and TAZ from the Scribble complexes and facilitating survival gene expression via activation of TEAD transcription factors. This pathway is also involved in some of the most important mechanisms that control the aging processes, such as the AMP-activated protein kinase and sirtuin pathways, along with autophagy and oxidative stress response/antioxidant defense. This could be the link between two tightly connected processes that could open a broader range of targeted molecular therapies to fight aging and cancer. Therefore, available knowledge of the processes involved in the Hippo pathway during aging and cancer must necess...
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research